2017 Annual Report: Collaboration Is Key to Maine Lung Cancer Coalition
Improving Access to Evidence-Based Lung Cancer Prevention & Care
In 2016, Maine Medical Center was awarded more than $5 million over four years to lead the efforts to improve the prevention, early detection and treatment of lung cancer in Maine. The initiative is primarily funded by:
- Bristol-Myers Squibb Foundation, $5 million
- Maine Cancer Foundation, $400,000
- Maine Economic Improvement Fund, $200,000, through the University of Southern Maine, as co-funders.
The Maine Lung Cancer Coalition, led by the MMC Research Institude, is an exciting new statewide, collaborative with two main goals:
1) Engage and educate the public, patients, providers, healthcare payers and policymakers about evidence-based lung cancer prevention and screening services;
2) Develop and evaluate innovative community-based strategies to increase access to evidence-based lung cancer prevention, screening and treatment services to the Maine population, focusing on high-risk individuals in rural, underserved communities.
The coalition held its inaugural Summit in May 2017 with health care providers, policy advocates and community organizations, and is building the processes, relationships and infrastructure to address this problem using evidence-based best practices.
In partnership with our members and other stakeholders, the coalition is piloting innovative approaches like using telemedicine for shared decision-making counseling screenings; conducting a statewide survey of PCPs to assess educational needs; and working to create a comprehensive data resource to share epidemiological information statewide.
For more information, visit the Lung Cancer Coalition.